Breaking News Instant updates and real-time market news.

CLB

Core Laboratories

$14.49 /

-0.56 (-3.72%)

17:05
10/21/20
10/21
17:05
10/21/20
17:05

Core Laboratories says pace of COVID recovery remains uncertain

The company states: "Conversations with Core's clients broadly reaffirm the Company's expectation that international projects already underway will continue; however, the pace and breadth of recovery from COVID-19 restrictions remains uncertain, making it difficult to forecast both the level and timing of such activity. Core Lab projects international activity in the fourth quarter of 2020 may slightly to modestly improve sequentially for both operating segments, if COVID-19 travel restrictions and supply chain disruptions begin to ease. Within Reservoir Description, Core expects reservoir fluid analysis, which accounts for more than 65% of the segment's revenue, to be more resilient as this work is diversified across the life of reservoir and less reliant on drilling and completion of new wells. U.S. land activity improved from the lows experienced during the middle of the second quarter as the third quarter of 2020 unfolded. This trend of gradual improvement in U.S. land activity is expected to continue into the fourth quarter of 2020. As a result, Core Lab projects overall fourth quarter 2020 U.S. land activity to modestly improve sequentially, and expects Production Enhancement to continue to track or outperform activity levels in U.S. land completions. Collectively, these trends point toward slightly to modestly improved sequential operational performance for Core Lab, barring any COVID-19-related retrenchments in client activity. Additionally, Core expects to generate positive FCF in the fourth quarter of 2020 as Core's aggressive adjustments to its cost structure further align with client activity, with continued focus on free cash generation and strategic debt reduction."

  • 22

    Oct

CLB Core Laboratories
$14.49 /

-0.56 (-3.72%)

10/13/20 BofA
Core Laboratories upgraded to Neutral from Underperform at BofA
10/13/20 BofA
Core Laboratories upgraded to Neutral from Underperform at BofA
09/29/20 ABN Amro
Core Laboratories upgraded to Hold from Sell at ABN Amro
07/16/20 Scotiabank
Core Laboratories downgraded to Sector Perform from Outperform at Scotiabank

TODAY'S FREE FLY STORIES

Technical Analysis
NYSE market internals summary » 11:16
11/23/20
11/23
11:16
11/23/20
11:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

General news
6-Month Bill Auction to be released at 11:30  11:15
11/23/20
11/23
11:15
11/23/20
11:15
 
General news
3-Month Bill Auction to be released at 11:30  11:15
11/23/20
11/23
11:15
11/23/20
11:15
 
General news
3-Month Bill Auction to be released at 11:30  11:15
11/23/20
11/23
11:15
11/23/20
11:15
 
General news
6-Month Bill Auction to be released at 11:30  11:15
11/23/20
11/23
11:15
11/23/20
11:15
 
General news
FX Action: USD-JPY » 11:10
11/23/20
11/23
11:10
11/23/20
11:10

FX Action: USD-JPY…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Neuronetics receives FDA 510k clearance for NeuroStar Advanced Therapy device » 11:06
11/23/20
11/23
11:06
11/23/20
11:06
STIM

Neuronetics

$7.78 /

-0.12 (-1.52%)

Neuronetics has received…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STIM Neuronetics
$7.78 /

-0.12 (-1.52%)

STIM Neuronetics
$7.78 /

-0.12 (-1.52%)

10/26/20 Canaccord
Neuronetics price target raised to $8 from $4 at Canaccord
10/06/20 BTIG
Neuronetics price target raised to $10 from $6 at BTIG
07/14/20 Piper Sandler
Investors should take 'fresh look' at Neuronetics after CEO hire, says Piper
05/05/20 William Blair
William Blair downgrades Neuronetics on restructuring uncertainty
STIM Neuronetics
$7.78 /

-0.12 (-1.52%)

STIM Neuronetics
$7.78 /

-0.12 (-1.52%)

Options
SmileDirectClub call volume above normal and directionally bullish » 11:05
11/23/20
11/23
11:05
11/23/20
11:05
SDC

SmileDirectClub

$12.00 /

+1.11 (+10.19%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDC SmileDirectClub
$12.00 /

+1.11 (+10.19%)

SDC SmileDirectClub
$12.00 /

+1.11 (+10.19%)

09/17/20 Stifel
SmileDirectClub price target raised to $14 from $11 at Stifel
09/09/20 Wolfe Research
Wolfe Research upgrades SmileDirectClub to Peer Perform as shifts pay off
09/09/20 Wolfe Research
SmileDirectClub upgraded to Peer Perform from Underperform at Wolfe Research
09/03/20 Stifel
SmileDirectClub imminent price increase can create 'solid' tailwind, says Stifel
SDC SmileDirectClub
$12.00 /

+1.11 (+10.19%)

  • 19
    Nov
SDC SmileDirectClub
$12.00 /

+1.11 (+10.19%)

SDC SmileDirectClub
$12.00 /

+1.11 (+10.19%)

SDC SmileDirectClub
$12.00 /

+1.11 (+10.19%)

Hot Stocks
Air Lease announces lease placement of 13 new Boeing 737 craft with Alaska Air » 11:03
11/23/20
11/23
11:03
11/23/20
11:03
ALL

Allstate

$101.08 /

+0.91 (+0.91%)

, ALK

Alaska Air

$48.70 /

+0.985 (+2.06%)

, BA

Boeing

$208.50 /

+8.88 (+4.45%)

, EADSY

Airbus

$0.00 /

+ (+0.00%)

Air Lease (AL) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALL Allstate
$101.08 /

+0.91 (+0.91%)

ALK Alaska Air
$48.70 /

+0.985 (+2.06%)

BA Boeing
$208.50 /

+8.88 (+4.45%)

EADSY Airbus
$0.00 /

+ (+0.00%)

ALL Allstate
$101.08 /

+0.91 (+0.91%)

11/17/20 Barclays
Allstate initiated with an Overweight at Barclays
09/22/20 Keefe Bruyette
Allstate upgraded to Outperform from Market Perform at Keefe Bruyette
07/22/20 Citi
Citi opens 'Positive Catalyst Watch' on Allstate shares
07/09/20 B. Riley FBR
National General downgraded to Neutral from Buy at B. Riley FBR
ALK Alaska Air
$48.70 /

+0.985 (+2.06%)

10/13/20 Susquehanna
Alaska Air upgraded to Positive from Neutral at Susquehanna
10/07/20 JPMorgan
Alaska Air price target raised to $64 from $55 at JPMorgan
09/30/20 Raymond James
Alaska Air price target raised to $50 from $43 at Raymond James
09/18/20 Barclays
Alaska Air price target raised to $40 from $37 at Barclays
BA Boeing
$208.50 /

+8.88 (+4.45%)

11/19/20 Susquehanna
Boeing price target raised to $275 from $220 at Susquehanna
11/18/20 Goldman Sachs
Boeing price target raised to $245 from $231 at Goldman Sachs
11/18/20 William Blair
Boeing 737 Max approval 'a modest positive' for ViaSat, says William Blair
11/18/20
Fly Intel: Top five analyst upgrades
EADSY Airbus
$0.00 /

+ (+0.00%)

11/13/20 JPMorgan
Airbus upgraded to Neutral from Underweight at JPMorgan
11/11/20 AlphaValue
Airbus upgraded to Add from Reduce at AlphaValue
11/05/20 Berenberg
Airbus price target raised to EUR 80 from EUR 76 at Berenberg
11/04/20 Nord/LB
Airbus upgraded to Hold from Sell at Nord/LB
ALL Allstate
$101.08 /

+0.91 (+0.91%)

ALK Alaska Air
$48.70 /

+0.985 (+2.06%)

BA Boeing
$208.50 /

+8.88 (+4.45%)

EADSY Airbus
$0.00 /

+ (+0.00%)

ALK Alaska Air
$48.70 /

+0.985 (+2.06%)

BA Boeing
$208.50 /

+8.88 (+4.45%)

EADSY Airbus
$0.00 /

+ (+0.00%)

ALL Allstate
$101.08 /

+0.91 (+0.91%)

ALK Alaska Air
$48.70 /

+0.985 (+2.06%)

BA Boeing
$208.50 /

+8.88 (+4.45%)

EADSY Airbus
$0.00 /

+ (+0.00%)

ALK Alaska Air
$48.70 /

+0.985 (+2.06%)

BA Boeing
$208.50 /

+8.88 (+4.45%)

Hot Stocks
Sensient to sell fragrance business to Symrise, terms not disclosed » 11:03
11/23/20
11/23
11:03
11/23/20
11:03
SXT

Sensient

$71.95 /

+1.21 (+1.71%)

, SYIEY

Symrise

$0.00 /

+ (+0.00%)

Sensient Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SXT Sensient
$71.95 /

+1.21 (+1.71%)

SXT Sensient
$71.95 /

+1.21 (+1.71%)

07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Stephens
Stephens starts Sensient with Overweight, calls it food tech's 'recovery' play
07/09/20 Stephens
Sensient initiated with an Overweight at Stephens
SYIEY Symrise
$0.00 /

+ (+0.00%)

11/19/20 Barclays
Symrise price target raised to EUR 106 from EUR 85 at Barclays
11/18/20 Barclays
Symrise price target raised to EUR 106 from EUR 85 at Barclays
11/09/20 Jefferies
Symrise initiated with a Hold at Jefferies
11/02/20 JPMorgan
Symrise price target raised to EUR 102 from EUR 93 at JPMorgan
SXT Sensient
$71.95 /

+1.21 (+1.71%)

Recommendations
ElectraMeccanica price target raised to $12.25 from $7.50 at Roth Capital » 11:01
11/23/20
11/23
11:01
11/23/20
11:01
SOLO

ElectraMeccanica

$10.70 /

-0.17 (-1.56%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SOLO ElectraMeccanica
$10.70 /

-0.17 (-1.56%)

SOLO ElectraMeccanica
$10.70 /

-0.17 (-1.56%)

10/29/20 Roth Capital
Roth reiterates Buy rating on ElectraMeccanica after first deliveries from China
04/03/20 Benchmark
ElectraMeccanica downgraded to Speculative Hold at Benchmark
SOLO ElectraMeccanica
$10.70 /

-0.17 (-1.56%)

SOLO ElectraMeccanica
$10.70 /

-0.17 (-1.56%)

Options
Plug Power call volume above normal and directionally bullish » 10:45
11/23/20
11/23
10:45
11/23/20
10:45
PLUG

Plug Power

$24.98 /

+0.61 (+2.50%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$24.98 /

+0.61 (+2.50%)

PLUG Plug Power
$24.98 /

+0.61 (+2.50%)

11/12/20 Canaccord
Plug Power price target raised to $25 from $13 at Canaccord
11/10/20 Craig-Hallum
Plug Power price target raised to $26 from $14 at Craig-Hallum
11/10/20 B. Riley Securities
Plug Power price target raised to $24 from $18 at B. Riley Securities
11/10/20 Roth Capital
Plug Power price target raised to $22 from $13 at Roth Capital
PLUG Plug Power
$24.98 /

+0.61 (+2.50%)

  • 17
    Nov
  • 12
    Aug
  • 06
    Dec
PLUG Plug Power
$24.98 /

+0.61 (+2.50%)

PLUG Plug Power
$24.98 /

+0.61 (+2.50%)

PLUG Plug Power
$24.98 /

+0.61 (+2.50%)

General news
FX Action: The dollar » 10:40
11/23/20
11/23
10:40
11/23/20
10:40

FX Action: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Man Group management to meet virtually with JPMorgan » 10:36
11/23/20
11/23
10:36
11/23/20
10:36
MNGPF

Man Group

$0.00 /

+ (+0.00%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNGPF Man Group
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Man Group price target raised to 153 GBp from 149 GBp at Morgan Stanley
10/19/20 UBS
Man Group price target raised to 155 GBp from 145 GBp at UBS
10/09/20 Morgan Stanley
Man Group price target lowered to $149 from $161 at Morgan Stanley
10/05/20 Jefferies
Man Group downgraded to Hold from Buy at Jefferies
Options
Gilead put volume heavy and directionally bearish » 10:35
11/23/20
11/23
10:35
11/23/20
10:35
GILD

Gilead

$59.93 /

-0.17 (-0.28%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$59.93 /

-0.17 (-0.28%)

GILD Gilead
$59.93 /

-0.17 (-0.28%)

11/20/20 Raymond James
Use of Gilead's remdesivir likely to skew to U.S. into Q1, says Raymond James
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Morgan Stanley
Gilead resumed with an Equal Weight at Morgan Stanley
10/29/20 BMO Capital
Gilead price target lowered to $64 from $74 at BMO Capital
GILD Gilead
$59.93 /

-0.17 (-0.28%)

GILD Gilead
$59.93 /

-0.17 (-0.28%)

GILD Gilead
$59.93 /

-0.17 (-0.28%)

GILD Gilead
$59.93 /

-0.17 (-0.28%)

Conference/Events
UBS consumer goods analyst to hold analyst/industry conference call » 10:30
11/23/20
11/23
10:30
11/23/20
10:30
KSS

Kohl's

$29.75 /

+1.34 (+4.72%)

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KSS Kohl's
$29.75 /

+1.34 (+4.72%)

KSS Kohl's
$29.75 /

+1.34 (+4.72%)

11/19/20 Morgan Stanley
Kohl's price target raised to $27 from $15 at Morgan Stanley
11/18/20 Credit Suisse
Kohl's price target raised to $30 from $23 at Credit Suisse
11/18/20 Deutsche Bank
Kohl's price target raised to $28 from $19 at Deutsche Bank
11/18/20 Citi
Kohl's price target raised to $33 from $21 at Citi
KSS Kohl's
$29.75 /

+1.34 (+4.72%)

KSS Kohl's
$29.75 /

+1.34 (+4.72%)

KSS Kohl's
$29.75 /

+1.34 (+4.72%)

KSS Kohl's
$29.75 /

+1.34 (+4.72%)

Syndicate
1Life Healthcare 7M share Block Trade priced at $33.65 » 10:27
11/23/20
11/23
10:27
11/23/20
10:27
ONEM

1Life Healthcare

$33.50 /

-1.92 (-5.42%)

Credit Suisse acted as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$33.50 /

-1.92 (-5.42%)

ONEM 1Life Healthcare
$33.50 /

-1.92 (-5.42%)

11/16/20 Truist
1Life Healthcare price target raised to $40 from $36 at Truist
11/11/20 Morgan Stanley
1Life Healthcare price target raised to $41 from $35 at Morgan Stanley
11/11/20 JPMorgan
1Life Healthcare price target raised to $43 from $40 at JPMorgan
11/11/20 Citi
1Life Healthcare price target raised to $42 from $38 at Citi
ONEM 1Life Healthcare
$33.50 /

-1.92 (-5.42%)

  • 23
    Nov
  • 25
    Jun
  • 31
    Jan
ONEM 1Life Healthcare
$33.50 /

-1.92 (-5.42%)

ONEM 1Life Healthcare
$33.50 /

-1.92 (-5.42%)

Options
Macy's call volume above normal and directionally bullish » 10:25
11/23/20
11/23
10:25
11/23/20
10:25
M

Macy's

$10.05 /

+1 (+11.06%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
M Macy's
$10.05 /

+1 (+11.06%)

M Macy's
$10.05 /

+1 (+11.06%)

11/20/20 Deutsche Bank
Macy's price target raised to $9 from $7 at Deutsche Bank
10/30/20 OTR Global
Macy's upgraded to Mixed from Negative at OTR Global
10/14/20 Morgan Stanley
Morgan Stanley, despite 'positive view' of new Macy's CFO, stays Underweight
09/04/20 Credit Suisse
No signs of improvement ahead for Macy's after 'solid' Q2, says Credit Suisse
M Macy's
$10.05 /

+1 (+11.06%)

M Macy's
$10.05 /

+1 (+11.06%)

M Macy's
$10.05 /

+1 (+11.06%)

M Macy's
$10.05 /

+1 (+11.06%)

General news
FX Action: The dollar » 10:25
11/23/20
11/23
10:25
11/23/20
10:25

FX Action: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Cantor Fitzgerald biopharma analysts to hold analyst/industry conference call » 10:25
11/23/20
11/23
10:25
11/23/20
10:25
GILD

Gilead

$59.85 /

-0.25 (-0.42%)

, LLY

Eli Lilly

$143.43 /

-2.21 (-1.52%)

, REGN

Regeneron

$521.45 /

+1.88 (+0.36%)

, HGEN

Humanigen

$8.72 /

-0.15 (-1.69%)

Biopharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$59.85 /

-0.25 (-0.42%)

LLY Eli Lilly
$143.43 /

-2.21 (-1.52%)

REGN Regeneron
$521.45 /

+1.88 (+0.36%)

HGEN Humanigen
$8.72 /

-0.15 (-1.69%)

GILD Gilead
$59.85 /

-0.25 (-0.42%)

11/20/20 Raymond James
Use of Gilead's remdesivir likely to skew to U.S. into Q1, says Raymond James
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Morgan Stanley
Gilead resumed with an Equal Weight at Morgan Stanley
10/29/20 BMO Capital
Gilead price target lowered to $64 from $74 at BMO Capital
LLY Eli Lilly
$143.43 /

-2.21 (-1.52%)

11/20/20 Stifel
Precision BioSciences price target raised to $22 from $21 at Stifel
11/17/20 Mizuho
Eli Lilly price target lowered to $156 from $164 at Mizuho
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform, $150 price target at Bernstein
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform at Bernstein
REGN Regeneron
$521.45 /

+1.88 (+0.36%)

04:56 Today Piper Sandler
Regeneron Covid cocktail could be meaningful to earnings, says Piper Sandler
11/11/20 Truist
Opthea initiated with a Buy at Truist
11/10/20 SVB Leerink
Regeneron price target lowered to $643 from $653 at SVB Leerink
11/06/20 Truist
Regeneron price target raised to $770 from $750 at Truist
HGEN Humanigen
$8.72 /

-0.15 (-1.69%)

11/06/20 H.C. Wainwright
Humanigen price target raised to $34 from $31 at H.C. Wainwright
10/21/20
Fly Intel: Top five analyst initiations
10/21/20 Cantor Fitzgerald
Humanigen initiated with an Overweight at Cantor Fitzgerald
10/20/20 Cantor Fitzgerald
Humanigen initiated with an Overweight at Cantor Fitzgerald
GILD Gilead
$59.85 /

-0.25 (-0.42%)

LLY Eli Lilly
$143.43 /

-2.21 (-1.52%)

REGN Regeneron
$521.45 /

+1.88 (+0.36%)

HGEN Humanigen
$8.72 /

-0.15 (-1.69%)

  • 18
    Sep
  • 27
    May
GILD Gilead
$59.85 /

-0.25 (-0.42%)

LLY Eli Lilly
$143.43 /

-2.21 (-1.52%)

REGN Regeneron
$521.45 /

+1.88 (+0.36%)

GILD Gilead
$59.85 /

-0.25 (-0.42%)

LLY Eli Lilly
$143.43 /

-2.21 (-1.52%)

REGN Regeneron
$521.45 /

+1.88 (+0.36%)

HGEN Humanigen
$8.72 /

-0.15 (-1.69%)

GILD Gilead
$59.85 /

-0.25 (-0.42%)

LLY Eli Lilly
$143.43 /

-2.21 (-1.52%)

REGN Regeneron
$521.45 /

+1.88 (+0.36%)

HGEN Humanigen
$8.72 /

-0.15 (-1.69%)

Periodicals
Diageo CEO says 'on the hunt' to buy more premium brands, CNBC reports » 10:23
11/23/20
11/23
10:23
11/23/20
10:23
DEO

Diageo

$156.26 /

-0.67 (-0.43%)

Diageo CEO Ivan Menezes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DEO Diageo
$156.26 /

-0.67 (-0.43%)

DEO Diageo
$156.26 /

-0.67 (-0.43%)

11/09/20 Barclays
Diageo price target raised to 3,040 GBp from 2,960 GBp at Barclays
10/15/20 BofA
Diageo reinstated with a Buy at BofA
10/07/20 Jefferies
Diageo upgraded to Buy from Underperform at Jefferies
10/05/20 Morgan Stanley
Diageo price target raised to 2,600 GBp from 2,500 GBp at Morgan Stanley
DEO Diageo
$156.26 /

-0.67 (-0.43%)

DEO Diageo
$156.26 /

-0.67 (-0.43%)

Technical Analysis
NASDAQ market internals summary » 10:17
11/23/20
11/23
10:17
11/23/20
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 10:16
11/23/20
11/23
10:16
11/23/20
10:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

General news
Treasury Action: yields remain higher but there wasn't much impact » 10:15
11/23/20
11/23
10:15
11/23/20
10:15

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
Supreme Court denies Walmart bid to sell alcohol in Texas, Bloomberg reports » 10:14
11/23/20
11/23
10:14
11/23/20
10:14
WMT

Walmart

$150.66 /

+0.42 (+0.28%)

The U.S. Supreme Court…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$150.66 /

+0.42 (+0.28%)

WMT Walmart
$150.66 /

+0.42 (+0.28%)

11/18/20 Raymond James
Walmart price target raised to $165 from $145 at Raymond James
11/18/20 DA Davidson
Walmart price target raised to $177 from $154 at DA Davidson
11/18/20 BMO Capital
Walmart price target raised to $175 from $160 at BMO Capital
11/18/20 MKM Partners
Walmart price target raised to $154 from $147 at MKM Partners
WMT Walmart
$150.66 /

+0.42 (+0.28%)

WMT Walmart
$150.66 /

+0.42 (+0.28%)

WMT Walmart
$150.66 /

+0.42 (+0.28%)

WMT Walmart
$150.66 /

+0.42 (+0.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.